Pharmaceutical collaboration between Russian and Chinese companies continues to grow, but entering the Russian market presents challenges in clinical trials, regulatory requirements, and drug registration. In this webinar, experts from OCT shared insights on drug registration in Russia, conducting clinical trials, strategies for biologics medicines, and navigating the local regulatory framework.
Hide player controls
Hide resume playing